254 related articles for article (PubMed ID: 21409414)
1. Advanced glycation end-products induce basement membrane hypertrophy in endoneurial microvessels and disrupt the blood-nerve barrier by stimulating the release of TGF-β and vascular endothelial growth factor (VEGF) by pericytes.
Shimizu F; Sano Y; Haruki H; Kanda T
Diabetologia; 2011 Jun; 54(6):1517-26. PubMed ID: 21409414
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end-products disrupt the blood-brain barrier by stimulating the release of transforming growth factor-β by pericytes and vascular endothelial growth factor and matrix metalloproteinase-2 by endothelial cells in vitro.
Shimizu F; Sano Y; Tominaga O; Maeda T; Abe MA; Kanda T
Neurobiol Aging; 2013 Jul; 34(7):1902-12. PubMed ID: 23428182
[TBL] [Abstract][Full Text] [Related]
3. [Blood-nerve barrier: structure and function].
Kanda T
Brain Nerve; 2011 Jun; 63(6):557-69. PubMed ID: 21613659
[TBL] [Abstract][Full Text] [Related]
4. Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier.
Shimizu F; Sano Y; Saito K; Abe MA; Maeda T; Haruki H; Kanda T
Neurochem Res; 2012 Feb; 37(2):401-9. PubMed ID: 22002662
[TBL] [Abstract][Full Text] [Related]
5. Effects of pericytes and various cytokines on integrity of endothelial monolayer originated from blood-nerve barrier: an in vitro study.
Iwasaki T; Kanda T; Mizusawa H
J Med Dent Sci; 1999 Mar; 46(1):31-40. PubMed ID: 12160211
[TBL] [Abstract][Full Text] [Related]
6. Blood-Nerve Barrier (BNB) Pathology in Diabetic Peripheral Neuropathy and In Vitro Human BNB Model.
Takeshita Y; Sato R; Kanda T
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374622
[TBL] [Abstract][Full Text] [Related]
7. [Peripheral neuropathy and blood-nerve barrier].
Kanda T
Rinsho Shinkeigaku; 2009 Nov; 49(11):959-62. PubMed ID: 20030260
[TBL] [Abstract][Full Text] [Related]
8. Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors.
Shimizu F; Sano Y; Abe MA; Maeda T; Ohtsuki S; Terasaki T; Kanda T
J Cell Physiol; 2011 Jan; 226(1):255-66. PubMed ID: 20665675
[TBL] [Abstract][Full Text] [Related]
9. Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier.
Shimizu F; Omoto M; Sano Y; Mastui N; Miyashiro A; Tasaki A; Maeda T; Koga M; Kaji R; Kanda T
J Neurol Neurosurg Psychiatry; 2014 May; 85(5):526-37. PubMed ID: 23926278
[TBL] [Abstract][Full Text] [Related]
10. Peripheral nerve pericytes originating from the blood-nerve barrier expresses tight junctional molecules and transporters as barrier-forming cells.
Shimizu F; Sano Y; Maeda T; Abe MA; Nakayama H; Takahashi R; Ueda M; Ohtsuki S; Terasaki T; Obinata M; Kanda T
J Cell Physiol; 2008 Nov; 217(2):388-99. PubMed ID: 18543246
[TBL] [Abstract][Full Text] [Related]
11. Tumor Necrosis Factor-α and IL-17A Activation Induces Pericyte-Mediated Basement Membrane Remodeling in Human Neutrophilic Dermatoses.
Lauridsen HM; Pellowe AS; Ramanathan A; Liu R; Miller-Jensen K; McNiff JM; Pober JS; Gonzalez AL
Am J Pathol; 2017 Aug; 187(8):1893-1906. PubMed ID: 28609645
[TBL] [Abstract][Full Text] [Related]
12. Curcumin reduces blood-nerve barrier abnormalities and cytotoxicity to endothelial cells and pericytes induced by cisplatin.
Kobutree P; Tothonglor A; Roumwong A; Jindatip D; Agthong S
Folia Morphol (Warsz); 2023; 82(3):533-542. PubMed ID: 35818807
[TBL] [Abstract][Full Text] [Related]
13. Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
Mancuso MR; Davis R; Norberg SM; O'Brien S; Sennino B; Nakahara T; Yao VJ; Inai T; Brooks P; Freimark B; Shalinsky DR; Hu-Lowe DD; McDonald DM
J Clin Invest; 2006 Oct; 116(10):2610-21. PubMed ID: 17016557
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of basement membrane-related molecules in rat brain pericyte, endothelial, and astrocyte cell lines after transforming growth factor-beta1 treatment.
Kose N; Asashima T; Muta M; Iizasa H; Sai Y; Terasaki T; Nakashima E
Drug Metab Pharmacokinet; 2007 Aug; 22(4):255-66. PubMed ID: 17827780
[TBL] [Abstract][Full Text] [Related]
15. Hydrocortisone enhances the function of the blood-nerve barrier through the up-regulation of claudin-5.
Kashiwamura Y; Sano Y; Abe M; Shimizu F; Haruki H; Maeda T; Kawai M; Kanda T
Neurochem Res; 2011 May; 36(5):849-55. PubMed ID: 21293925
[TBL] [Abstract][Full Text] [Related]
16. Effect of VEGF-A on expression of profibrotic growth factor and extracellular matrix genes in the retina.
Kuiper EJ; Hughes JM; Van Geest RJ; Vogels IM; Goldschmeding R; Van Noorden CJ; Schlingemann RO; Klaassen I
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4267-76. PubMed ID: 17724216
[TBL] [Abstract][Full Text] [Related]
17. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
[TBL] [Abstract][Full Text] [Related]
18. Reduced pericyte and tight junction coverage in old diabetic rats are associated with hyperglycemia-induced cerebrovascular pericyte dysfunction.
Liu Y; Zhang H; Wang S; Guo Y; Fang X; Zheng B; Gao W; Yu H; Chen Z; Roman RJ; Fan F
Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H549-H562. PubMed ID: 33306445
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic strategy for peripheral nerve regeneration; molecular permeability control at the blood-nerve barrier].
Kanda T
Rinsho Shinkeigaku; 2008 Nov; 48(11):1028-30. PubMed ID: 19198153
[TBL] [Abstract][Full Text] [Related]
20. Differential TGF-{beta} signaling in retinal vascular cells: a role in diabetic retinopathy?
Van Geest RJ; Klaassen I; Vogels IM; Van Noorden CJ; Schlingemann RO
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1857-65. PubMed ID: 19959647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
